These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 23258573)

  • 1. No contribution of IP3-R(2) to disease phenotype in models of dilated cardiomyopathy or pressure overload hypertrophy.
    Cooley N; Ouyang K; McMullen JR; Kiriazis H; Sheikh F; Wu W; Mu Y; Du XJ; Chen J; Woodcock EA
    Circ Heart Fail; 2013 Mar; 6(2):318-25. PubMed ID: 23258573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of copper and homocysteine in pressure overload heart failure.
    Hughes WM; Rodriguez WE; Rosenberger D; Chen J; Sen U; Tyagi N; Moshal KS; Vacek T; Kang YJ; Tyagi SC
    Cardiovasc Toxicol; 2008; 8(3):137-44. PubMed ID: 18679830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene expression analysis to identify mechanisms underlying heart failure susceptibility in mice and humans.
    Koentges C; Pepin ME; Müsse C; Pfeil K; Alvarez SVV; Hoppe N; Hoffmann MM; Odening KE; Sossalla S; Zirlik A; Hein L; Bode C; Wende AR; Bugger H
    Basic Res Cardiol; 2018 Jan; 113(1):8. PubMed ID: 29288409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphoinositide 3-kinase p110α is a master regulator of exercise-induced cardioprotection and PI3K gene therapy rescues cardiac dysfunction.
    Weeks KL; Gao X; Du XJ; Boey EJ; Matsumoto A; Bernardo BC; Kiriazis H; Cemerlang N; Tan JW; Tham YK; Franke TF; Qian H; Bogoyevitch MA; Woodcock EA; Febbraio MA; Gregorevic P; McMullen JR
    Circ Heart Fail; 2012 Jul; 5(4):523-34. PubMed ID: 22705768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteopontin RNA aptamer can prevent and reverse pressure overload-induced heart failure.
    Li J; Yousefi K; Ding W; Singh J; Shehadeh LA
    Cardiovasc Res; 2017 May; 113(6):633-643. PubMed ID: 28453726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of dilated cardiomyopathy in Bmal1-deficient mice.
    Lefta M; Campbell KS; Feng HZ; Jin JP; Esser KA
    Am J Physiol Heart Circ Physiol; 2012 Aug; 303(4):H475-85. PubMed ID: 22707558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term miR-669a therapy alleviates chronic dilated cardiomyopathy in dystrophic mice.
    Quattrocelli M; Crippa S; Montecchiani C; Camps J; Cornaglia AI; Boldrin L; Morgan J; Calligaro A; Casasco A; Orlacchio A; Gijsbers R; D'Hooge J; Toelen J; Janssens S; Sampaolesi M
    J Am Heart Assoc; 2013 Aug; 2(4):e000284. PubMed ID: 23963759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substrain specific response to cardiac pressure overload in C57BL/6 mice.
    Garcia-Menendez L; Karamanlidis G; Kolwicz S; Tian R
    Am J Physiol Heart Circ Physiol; 2013 Aug; 305(3):H397-402. PubMed ID: 23709599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. O-ring-induced transverse aortic constriction (OTAC) is a new simple method to develop cardiac hypertrophy and heart failure in mice.
    Nakao Y; Aono J; Hamaguchi M; Takahashi K; Sakaue T; Inoue K; Ikeda S; Yamaguchi O
    Sci Rep; 2022 Jan; 12(1):85. PubMed ID: 34997065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of ADAM15 in female mice does not worsen pressure overload cardiomyopathy, independent of ovarian hormones.
    Krishnan V; Atanasova N; Aujla PK; Hupka D; Owen CA; Kassiri Z
    Am J Physiol Heart Circ Physiol; 2024 Aug; 327(2):H409-H416. PubMed ID: 38607341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Basigin Promotes Cardiac Fibrosis and Failure in Response to Chronic Pressure Overload in Mice.
    Suzuki K; Satoh K; Ikeda S; Sunamura S; Otsuki T; Satoh T; Kikuchi N; Omura J; Kurosawa R; Nogi M; Numano K; Sugimura K; Aoki T; Tatebe S; Miyata S; Mukherjee R; Spinale FG; Kadomatsu K; Shimokawa H
    Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):636-46. PubMed ID: 26916734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutrophil Extracellular Traps in Myocardial Tissue Drive Cardiac Dysfunction and Adverse Outcomes in Patients With Heart Failure With Dilated Cardiomyopathy.
    Ichimura S; Misaka T; Ogawara R; Tomita Y; Anzai F; Sato Y; Miura S; Yokokawa T; Sato T; Oikawa M; Kobayashi A; Yoshihisa A; Takeishi Y
    Circ Heart Fail; 2024 Jun; 17(6):e011057. PubMed ID: 38847093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The magnitude of left ventricular myocardial hypertrophy related to the degree of its dysfunction in patients with dilated cardiomyopathy (DCM).
    Petkow-Dimitrow P; Kałuza G; Turek P; Dubiel D; Legutko J; Dubiel JS
    Cor Vasa; 1992; 34(3):209-17. PubMed ID: 1306417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pressure Overload by Transverse Aortic Constriction Induces Maladaptive Hypertrophy in a Titin-Truncated Mouse Model.
    Zhou Q; Kesteven S; Wu J; Aidery P; Gawaz M; Gramlich M; Feneley MP; Harvey RP
    Biomed Res Int; 2015; 2015():163564. PubMed ID: 26504781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential cardiac hypertrophy and signaling pathways in pressure versus volume overload.
    You J; Wu J; Zhang Q; Ye Y; Wang S; Huang J; Liu H; Wang X; Zhang W; Bu L; Li J; Lin L; Ge J; Zou Y
    Am J Physiol Heart Circ Physiol; 2018 Mar; 314(3):H552-H562. PubMed ID: 29196344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Connective tissue growth factor regulates cardiac function and tissue remodeling in a mouse model of dilated cardiomyopathy.
    Koshman YE; Sternlicht MD; Kim T; O'Hara CP; Koczor CA; Lewis W; Seeley TW; Lipson KE; Samarel AM
    J Mol Cell Cardiol; 2015 Dec; 89(Pt B):214-22. PubMed ID: 26549358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Requirement for Ca2+/calmodulin-dependent kinase II in the transition from pressure overload-induced cardiac hypertrophy to heart failure in mice.
    Ling H; Zhang T; Pereira L; Means CK; Cheng H; Gu Y; Dalton ND; Peterson KL; Chen J; Bers D; Brown JH
    J Clin Invest; 2009 May; 119(5):1230-40. PubMed ID: 19381018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Galectin-3 deficiency ameliorates fibrosis and remodeling in dilated cardiomyopathy mice with enhanced Mst1 signaling.
    Nguyen MN; Ziemann M; Kiriazis H; Su Y; Thomas Z; Lu Q; Donner DG; Zhao WB; Rafehi H; Sadoshima J; McMullen JR; El-Osta A; Du XJ
    Am J Physiol Heart Circ Physiol; 2019 Jan; 316(1):H45-H60. PubMed ID: 30387702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of RyR2 phosphorylation at S2814 during heart failure progression.
    Respress JL; van Oort RJ; Li N; Rolim N; Dixit SS; deAlmeida A; Voigt N; Lawrence WS; Skapura DG; Skårdal K; Wisløff U; Wieland T; Ai X; Pogwizd SM; Dobrev D; Wehrens XH
    Circ Res; 2012 May; 110(11):1474-83. PubMed ID: 22511749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin II type 2 receptor is upregulated in human heart with interstitial fibrosis, and cardiac fibroblasts are the major cell type for its expression.
    Tsutsumi Y; Matsubara H; Ohkubo N; Mori Y; Nozawa Y; Murasawa S; Kijima K; Maruyama K; Masaki H; Moriguchi Y; Shibasaki Y; Kamihata H; Inada M; Iwasaka T
    Circ Res; 1998 Nov; 83(10):1035-46. PubMed ID: 9815151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.